Pipeline pharmacogenetics: a novel approach to integrating pharmaco-genetics into drug development.
Journal Article (Review;Journal Article)
There has been a decline in the number of new drugs registered over the past decade and regulatory concerns for safety as well as payer concerns for efficacy have focused attention on stratified medicine. Integration of pharmacogenetics into the drug development pipeline will contribute to the development of new stratified drugs. We describe here the concept of pipeline pharmacogenetics and its application throughout the phases of drug discovery. Pipeline pharmacogenetics enables the evaluation of the genetic contribution to safety potentially lowering barriers to registration as well as providing rationale for efficacy and enabling co-development of genetic in vitro diagnostics.
Full Text
Duke Authors
Cited Authors
- Akkari, PA; Swanson, TW; Crenshaw, DG; Grossman, I; Sundseth, S; Burns, DK; Roses, AD
Published Date
- January 2009
Published In
Volume / Issue
- 15 / 32
Start / End Page
- 3754 - 3763
PubMed ID
- 19925426
Electronic International Standard Serial Number (EISSN)
- 1873-4286
International Standard Serial Number (ISSN)
- 1381-6128
Digital Object Identifier (DOI)
- 10.2174/138161209789649538
Language
- eng